1
Davis Ward Ronda, Mook Robert Anthony Jr, Neeb Michael J, Salovich James M: Pyrimidine compounds. Smithkline Beecham Corporation, Davis Ward Ronda, Mook Robert Anthony Jr, Neeb Michael J, Salovich James M, LEVY David J, September 2, 2004: WO/2004/074244 (95 worldwide citation)

The present invention provides compounds of formula (I) : wherein all variables are as defined herein, pharmaceutical compositions containing the same, processes for preparing the same and their use as pharmaceutical agents.


2
Bondinell William E, Neeb Michael J: Substituted heterocyclic compounds as modulators of the ccr5 receptor. Smithkline Beecham Corporation, Bondinell William E, Neeb Michael J, STEIN FERNANDEZ Nora, February 5, 2004: WO/2004/010942 (28 worldwide citation)

This invention relates to substituted heterocyclic compounds which are modulators, agonists or antagonists, of the CCR5 receptor. In addition, this invention relates to the treatment and prevention of disease states mediated by CCR5, including, but not limited to, asthma and atopic disorders (for ex ...


3
Bondinell William E, Neeb Michael J: Substituted benzanilides as modulators of the ccr5 receptor. Smithkline Beecham Corporation, Bondinell William E, Neeb Michael J, STEIN FERNANDEZ Nora, February 5, 2004: WO/2004/011427 (28 worldwide citation)

This invention relates to substituted benzanilides which are modulators, agonists or antagonists, of the CCR5 receptor. In addition, this invention relates to the treatment and prevention of disease states mediated by CCR5, including, but not limited to, asthma and atopic disorders (for example, ato ...


4
Bondinell William E, Neeb Michael J: Substituted benzanilides as modulators of the ccr5 receptor. Smithkline Beecham Corporation, Bondinell William E, Neeb Michael J, STEIN FERNANDEZ Nora, February 5, 2004: WO/2004/010943 (20 worldwide citation)

This invention relates to substituted benzanilides which are modulators, agonists or antagonists, of the CCR5 receptor. In addition, this invention relates to the treatment and prevention of disease states mediated by CCR5, including, but not limited to, asthma and atopic disorders (for example, ato ...


5
Barton Linda S, Louer Christopher T, Mcatee John Jeffrey, Neeb Michael J, Wang Ning: Sulfonamides. Smithkline Beecham Corporation, Barton Linda S, Louer Christopher T, Mcatee John Jeffrey, Neeb Michael J, Wang Ning, HALL Linda E, May 27, 2004: WO/2004/043368 (5 worldwide citation)

The present invention relates to sulfonamides, pharmaceutical compositions containing them, and their use as antagonists of urotensin II.


6

7

8
Girard Gerald R, Mcatee John Jeffrey, Neeb Michael J: Sulfonamides. Smithkline Beecham Corporation, Girard Gerald R, Mcatee John Jeffrey, Neeb Michael J, HALL Linda E, May 27, 2004: WO/2004/043369 (4 worldwide citation)

The present invention relates to sulfonamides, pharmaceutical compositions containing them, and their use as antagonists of urotensin II.


9
Neeb Michael J: Sulfonamides. Smithkline Beecham Corporation, Neeb Michael J, HALL Linda E, May 27, 2004: WO/2004/043463 (4 worldwide citation)

The present invention relates to sulfonamides, pharmaceutical compositions containing them, and their use as antagonists of urotensin II.


10
Dodson Jason W, Mcatee John Jeffrey, Neeb Michael J: Sulfonamides. Smithkline Beecham Corporation, Dodson Jason W, Mcatee John Jeffrey, Neeb Michael J, HALL Linda E, May 27, 2004: WO/2004/043948 (4 worldwide citation)

The present invention relates to sulfonamides, pharmaceutical compositions containing them, and their use as antagonists of urotensin II.